Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2009, p. 925-930, Vol. 75, No. 4
0099-2240/09/$08.00+0 doi:10.1128/AEM.01998-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

EMA, Centre LGEI, 6 Avenue de Clavières, 30100 Alès, France,1 NPP (Arysta LifeScience), 35 Avenue Léon Blum, 64000 Pau, France,2 IRD, 158 Avenue Charles de Gaulle, 30380 St. Christol-les-Alès, France,3 INRA, Unité PSH, Agroparc, 84914 Avignon Cedex 9, France4
Received 28 August 2008/ Accepted 17 December 2008
|
|
|---|
|
|
|---|
The codling moth, Cydia pomonella (L.), is a major pest causing severe economic damage in apple and pear orchards throughout most of the temperate world (9). Intensive chemical control led to resistance to most classes of insecticides (27, 31). Since the registration of the Cydia pomonella granulovirus (CpGV) (Baculoviridae), the use of this biological product in codling moth control has increased continuously due to both the increasing interest toward organic farming and the spread of resistance to synthetic chemical insecticides. Various baculoviruses are used in biological control. Most belong to the nucleopolyhedrovirus genus. Among those belonging to the second genus of the baculovirus family, the granulovirus, CpGV is one of the most commonly used, both in organic farming and in conventionally managed orchards.
In 2003, suspicions of field resistance to the virus were raised first in Germany (14) and then in France. Resistance was confirmed for several C. pomonella populations collected in organic orchards where CpGV treatments had failed (3, 30). This resistance to CpGV is the first case of resistance to a virus observed in field populations of an insect. As control failures permit an increase in the density of the insect population, the risk of dispersal of the resistance trait is high. Development of resistance against CpGV is, therefore, a major issue for apple production.
The first CpGV isolate was found in Mexico and was described by Tanada in 1964 (34). In Europe, all commercial formulations of CpGV are derived from this Mexican isolate (CpGV-M). The genome of CpGV-M1, a genotype isolated from the CpGV-M population by an in vivo limiting dilution method, was first characterized by restriction enzyme fragment length polymorphism (7). Then, it was completely sequenced (25), and this has become the reference genotype. Two additional CpGV genotypic variants have been described and classified according to their geographical origins: the R type, from Russia, and the E-type, from England (8, 17). Usually, the characterization of a new isolate is made by comparison with these three genotypes, M, R, and E. This classification is based on modifications in some restriction fragments and is not directly related to the biological properties of the variants.
Among the principal differences between chemical and biological control agents are the genetic diversity of the latter and their ability to evolve when conditions allow adaptation of the pathogen to the host. Success in adaptation to homologous or heterologous hosts by serial passages has been reported for baculoviruses (21, 26). The approach developed in this study was to survey existing isolates for their efficacy against the resistant codling moth and then to examine the possible adaptation of the most pathogenic candidate to the resistant host by serial passages through a laboratory colony of C. pomonella originating from field-collected resistant insects.
|
|
|---|
Diapausing larvae collected during the 2004 season in an organic orchard (St. Andiol, Bouches du Rhône, France) in which CpGV-based control had failed were used to start a virus-resistant laboratory colony. Their offspring were challenged with the commercial CpGV-M formulation to select the resistant individuals. This resistant laboratory colony was named RGV. To allow precise comparisons between Sv and RGV, it was important to homogenize their genetic composition. For that, an introgression of the resistance trait was performed by successive backcrosses with the Sv colony. At each generation, the resistant larvae were selected by exposing the population to a discriminating concentration of virus defined previously (30). After four successive backcrosses (RGV.4), the RGV colony was maintained for four additional generations under continuous virus selection. This colony was used for the bioassays in 2007. The introgression of the resistance trait was then continued until the eighth backcross (RGV.8), also followed by four generations of selection (Fig. 1). This colony, named RGV.8, was used in 2008.
![]() View larger version (22K): [in a new window] |
FIG. 1. Introgression of the resistance trait into the Sv-associated susceptible genetic background.
|
The I12 isolate was provided by M. Rezapanah from PPDRI (Pests and Deseases Research Institute, Teheran, Iran) and by J. Jehle from DLR (Dienstleistungszentrum Ländlicher Raum, Neustadt, Germany). This isolate, originally from Iran, was recently shown to overcome CpGV resistance in a German population of C. pomonella (10).
The NPP-R1 isolate was provided by NPP. This isolate comes from the virus collection of the firm. The original stock was amplified using the susceptible colony reared at the NPP facility prior to use in bioassays. The 2016-r4 isolate is the result of four cycles of multiplication of NPP-R1 on RGV larvae.
These four isolates (CpGV-M, I12, NPP-R1, and 2016-r4) were used for restriction analysis of the DNA and for bioassays. The occlusion body (OB) concentration of each viral stock was determined using a light microscope (Olympus BX41TF) with dark field optics (x600) and a Petroff-Hauser counting chamber (depth, 0.01 mm).
Virus multiplication on RGV larvae.
A series of viral passages on RGV larvae were carried out, starting from the NPP-R1 isolate. Third-instar RGV larvae (7 days old) reared on a virus-free diet were infected with OBs produced in the previous passage. A 50-µl suspension comprising between 1 x 104 and 2 x 104 OBs/µl was deposited on the surface of a formaldehyde-free insect diet (Heliothis Diet; Stonefly Industries, TX) in 24-well plates. Approximately 50 larvae per passage were inoculated and incubated at 25°C with a 16:8-h (light/dark) photoperiod. Diseased larvae were extracted from the rearing diet at early signs of viral infection, usually from the fourth to the seventh day postinoculation, and stored at 25°C until death. The dead larvae were homogenized in distilled water, and the resulting suspension was filtered through nylon to remove insect debris. The filtrate was centrifuged twice at 10,000 x g for 30 min, and the pellet was resuspended in distilled water. This suspension constituted the inoculum for the following viral passage.
DNA extraction and restriction endonuclease (REN) analysis of CpGV isolates.
To isolate viral DNA, OBs were dissolved in 0.1 M Na2CO3. Viral DNA was extracted twice with an equal volume of phenol and once with chloroform. DNA was then precipitated in cold ethanol (70%, vol/vol) in the presence of 0.2 M sodium acetate and incubated overnight at –20°C. Samples were centrifuged for 30 min at 10,000 x g to collect the nucleic acid precipitate. Resulting pellets were washed with 70% cold ethanol, dried, and resuspended into distilled water.
Approximately 500 ng of purified virus DNA was digested with EcoRI, BamHI, PstI, SalI, or XhoI (Fermentas) in the supplied buffer at 37°C for 3 h. The DNA restriction fragments were separated by electrophoresis in 1% agarose gels in Tris-acetate-EDTA buffer at 80 V for approximately 4 h.
-phage DNA/HindIII fragments were used as standards for size determination. Fragments were visualized under UV light by ethidium bromide staining. The fragment sizes and DNA quantity were estimated using the Kodak 1D image system (Eastman Kodak Company).
PCR amplification and REN analysis of the PCR product.
PCR was carried out using primer sets CPGV3F (5'-AAA CGA GGA CCG TCA AAA TG-3') and CPGV3R (5'-CTC GGA CAA TGA ACG TGT TG-3'), located at nucleotides (nt) 54513 and 58482 on the CpGV-M1 sequence (GB-U53466). These primers generate a PCR product of about 4,000 bp. The amplified DNA was tested for the presence of an EcoRI restriction site by treatment with the endonuclease followed by electrophoresis as described above.
Bioassays.
Bioassays against neonate larvae (0 to 12 h old) were carried out using a diet surface contamination method in 96-well plates containing about 200 µl of a formaldehyde-free artificial diet (Heliothis Diet; Stonefly Industries, TX). A 6-µl volume of an OB suspension was spread over the diet surface of each well (well surface area = 28 mm2). The same volume of distilled water was used in control wells. Bioassays were performed using five or six CpGV concentrations, ranging from 3 to 729 OBs/µl for the most efficient isolates (corresponding to 0.643 to 156.2 OBs/mm2 of diet surface) and up to 3.125 x 106 OBs/µl for the RGV colony for the least efficient isolate (6.696 x 105 OBs/mm2). One larva was placed in each well. The wells were sealed with parafilm, and the microplates were incubated in a growth chamber at 25°C with a 16:8-h (light/dark) photoperiod. The larvae that died within the first day postinoculation were excluded from the test. Mortality was recorded at 7 days postinfection. Larvae that did not react to physical stimuli were considered dead.
To avoid any bias in the results due to a reduction in pathogenicity of the virus or a variation in susceptibility of the hosts, the data were analyzed independently each year. Mortality data were subjected to probit analysis (13) after correction for control mortality (1).
|
|
|---|
![]() View larger version (69K): [in a new window] |
FIG. 2. Agarose gel electrophoresis of CpGV-M DNA and NPP-R1 DNA digested with EcoRI. Arrows indicate additional or modified fragments. Lambda-DNA digested with HindIII is included for molecular size standards (L).
|
![]() View larger version (86K): [in a new window] |
FIG. 3. DNA restriction profiles for EcoRI, SalI, XhoI, BamHI, and PstI. Lanes M represent the CpGV-M DNA, and lane r4 represents the 2016-r4 DNA. Arrows indicate additional or modified fragments. Lambda-DNA digested with HindIII is included for molecular size standards (L).
|
Bioassays. (i) Resistance ratio of the RGV colony.
Under our experimental conditions, the CpGV-M presented a 50% lethal concentration (LC50) of 25 to 30 OBs/µl on Sv (Table 1). In 2007, the LC50 obtained for RGV.4 by using CpGV-M07 was 1.38 x 106 OBs/µl, which represents a resistance factor of 60,000-fold between Sv and RGV colonies. In 2008, upon treatment with CpGV-M08, the LC50 for RGV.8 was 2.37 x 106 OBs/µl, which was not significantly different from the value estimated in 2007 (
2 = 0.844; df = 3; P = 0.8389). Moreover, considering the LC50 of Sv treated with CpGV-M08 (29.22 OBs/µl), the resistance factor of 80,000-fold in 2008 was considered to be equivalent to that for 2007.
|
View this table: [in a new window] |
TABLE 1. Pathogenicities, measured by LC50 and LC90, of four virus isolates on C. pomonella laboratory colonies susceptible (Sv) and resistant (RGV) to CpGV-Ma
|
2 = 0.178; df = 3; P = 0.9811) (Table 1). With an estimated LC50 of 5.01 x 103 OBs/µl on RGV larvae, I12 presented a significantly higher pathogenicity than CpGV-M (
2 = 118.5; df = 3; P < 0.0001). The resistance factor at the LC50 between the Sv and RGV colonies was reduced from 60,000-fold (the level for inoculation with CpGV-M) to 200-fold (upon inoculation with I12).
As for the I12 isolate, the biological activities of the CpGV-M07 and NPP-R1 isolates on Sv larvae were similar (LC50s of 24.0 OBs/µl and 25.8 OBs/µl, respectively;
2 = 0.228; df = 3; P = 0.9730) (Table 1). In contrast, the biological activities of NPP-R1 and CpGV-M07 on RGV larvae differed significantly (LC50s of 166 OBs/µl and 1.38 x 106 OBs/µl, respectively;
2 = 229; df = 3; P < 0.0001). The RGV resistance factor of 60,000-fold in CpGV-M07 was thus reduced to 7-fold in NPP-R1. Accordingly, the potency of NPP-R1 was close to 10,000-fold higher than that of CpGV-M on resistant larvae.
The slopes of concentration-mortality regression were not significantly different among the three viral isolates CpGV-M07, I12, and NPP-R1 for the same C. pomonella colony (Sv [
2 = 0.278; df = 2; P = 0.870] and RGV [
2 = 1.395; df = 2; P = 0.498]). Conversely, significant differences were observed for the slopes with same isolate between the Sv and RGV colonies (CpGV-M07 [
2 = 25.5; df = 1; P < 0.0001], I12 [
2 = 7.749; df = 1; P = 0.0054], and NPP-R1 [
2 = 9.78; df = 1; P = 0.0018]). The slope for resistant larvae was shallower than that for susceptible insects. The resistance ratio of the RGV colony treated with NPP-R1 was thus higher at the LC90 than at the LC50, reaching a ratio of 46-fold instead of 7-fold (Table 1). Similarly, the resistance factor of the RGV colony to I12 was higher at the LC90 than at the LC50, reaching 1,000-fold instead of a 200-fold ratio.
(iii) Biological activity of 2016-r4.
To determine if the amplification of NPP-R1 on RGV larvae resulted in a modification of the virus efficiency, the biological activity of 2016-r4 was evaluated using bioassays on both Sv and RGV colonies. On the Sv colony, the LC50s of 2016-r4 and CpGV-M08 on Sv larvae did not differ significantly (
2 = 4.0; df = 3; P = 0.261) (Table 1). In contrast, the LC50 of RGV larvae treated with 2016-r4 decreased to 102 OBs/µl, which represented a reduction in resistance ratio from 7-fold for NPP-R1 to 3.5-fold for 2016-r4. The most relevant improvement of efficiency was observed at the LC90, which was reduced from 1.28 x 104 OBs/µl (NPP-R1) to 1.57 x 103 OBs/µl (2016-r4). As a result, the slopes of the concentration-mortality regressions of 2016-r4 on Sv and RGV were no longer significantly different (
2 = 0.603; df = 1; P = 0.437). Since the concentration-mortality lines could be considered parallel, the value for the relative potency between CpGV-M on Sv larvae and 2016-r4 on RGV was estimated to be 4.0.
|
|
|---|
As the improvement in the control of RGV larvae by I12 did not reach appropriate levels for its commercial use (Table 1), the search for new isolates with greater efficiency against RGV larvae has been pursued. Among the various original isolates that were tested on RGV (data not shown), a new isolate, NPP-R1, showed the highest efficacy, with a reduction in resistance ratio from 60,000- to 7-fold at the LC50. Field trials with NPP-R1 were performed in 2007 in fields with confirmed resistance in France and Germany, but no significant reduction of pest infestation was achieved by applications of NPP-R1, compared to levels for applications involving CpGV-M (data not shown). There are various possible explanations for these results. First, the LC90 probably represents a better estimation of the field efficiency of an insecticide than the LC50, as high dosages are required for effective pest suppression. Therefore, the high LC90 value of the NPP-R1 isolate against RGV (1.28 x 104 OBs/µl) may result in low efficacy for a field application. Second, the failure to control C. pomonella populations in the field with the NPP-R1 isolate could be explained by a RGV colony that is unrepresentative of the field populations (for example, coexistence of more than one resistant genotype, lost during the RGV selection process). Finally, the CpGV-R1 isolate might not resist field conditions as well as CpGV-M, resulting in its rapid inactivation. The efficiency of NPP-R1, and of any new isolate, should be systematically verified using both laboratory bioassays and field trials on representative insect populations that differ in susceptibility to CpGV-M.
Restriction fragment enzyme length polymorphism analysis revealed that NPP-R1 is a mixture of genotypes. PCR amplification followed by EcoRI digestion allowed us to determine that two major genotypes constitute the NPP-R1 isolate. Of these genotypes, a CpGV-M1-like genotype was present at a prevalence of ca. 30%. The unidentified submolar band of 4.4 kb may belong to a third genotype, similar to the R1 genotype. The analysis of CpGV-M (7) did not reveal any genetic variability in this isolate. However, a recent analysis of natural virus isolates from Iran revealed a high proportion of genotypic mixtures (29). It seems that GV populations are composed of distinct genotypes, as are those of the best-studied nuclear polyhedrosis virus (32).
The passages on RGV resulted in the adaptation of the NPP-R1 isolate to the new, more uniform, more restrictive host conditions. This adaptation is likely to have affected the original genetic composition of the isolate. The CpGV-M genotype that is inefficient against RGV larvae was reduced to an undetectable level in fewer than four passages. The selection of the 2016-r4 isolate free of CpGV-M resulted in a slight improvement in the LC50 in RGV larvae and an eightfold improvement in LC90 (from 1.28 x 104 OBs/µl to 1.57 x 103 OBs/µl). This reduction in LC90 should have an important impact on the level of control of the insect population. In a Spodoptera frugiperda nucleopolyhedrovirus isolate, an increase of pathogenicity was observed only when various genotypes coexisted in the same larvae. Among them, one genotype was not able to infect alone (24). For NPP-R1, our results confirmed that the R1 genotype alone was indeed responsible for overcoming the resistance in the insect colony; the M type present in NPP-R1 was not required for R1 multiplication. The submolar band of 4.4 kb resulting from the EcoRI digestion of NPP-R1 DNA was still present in 2016-r4, although at a reduced intensity. 2016-r4 is probably not a single genotype but a group of closely related genotypes, indistinguishable with the five enzymes used. The 2016-r4 restriction profile clearly indicates that the R1 genotype is a CpGV variant. Three previously described CpGV variants, the Mexican (M), the English (E), and the Russian (R) variants, present some differential genotypic characteristics. The R type has a single deletion of about 2.4 kbp in the total genome, and the E type is modified in one area, resulting in an additional EcoRI site, a shift in a BamHI, site and a total insertion of 0.8 kbp (deletion of 0.3 kbp and insertion of 1.1 kbp) (8). The R1 genotype is different from all three variants. R1 also differs from the CpGV-I12 isolate described by Eberle et al. (10), which overcomes the CpGV-M resistance in German populations of C. pomonella. To date, after only a few years of investigation, two different isolates have been identified as active against resistant larvae, with different levels of efficiency.
The concentration-mortality lines of 2016-r4 on RGV and CpGV-M on Sv were estimated to be parallel, suggesting that the pathogenicities of both virus populations in these alternative hosts follow similar dynamics. Continuous selection on RGV larvae might lead to a virus isolate even more efficient against this larval phenotype. However, increasing virus pathogenicity could reduce the isolate's pathogenicity against susceptible larvae. Some studies have shown that serial passages could favor the proliferation of defective genotypes (6, 23). No statistically significant differences were detected in the pathogenicities of 2016-r4 and CpGV-M on Sv larvae after four cycles of selection. It seems that the increased performance of 2016-r4 on RGV is not counterbalanced by a decrease in pathogenicity in the other host. Alternatively, this adaptation could influence other biological properties of the virus, like OB production or speed of kill, as observed for other insect viruses (5). It has been shown that increasing the speed of kill results in a lower OB yield (22, 28), but to our knowledge, no direct relationship with pathogenicity (LC50) or other biological traits has been reported.
The rapid response to the selection of NPP-R1 indicates that the virus isolate already contained a genotype able to control the RGV-associated resistant phenotype. However, the 88% decrease in the 2016-r4 LC90 value is higher than would be expected following the elimination of the M genotype, since it represents only
30% of the total genotypic composition of the NPP-R1 isolate. In-depth analysis would be required to determine whether there is interference between the M and R1 genotypes or additional changes in the R1 genome that have occurred during the adaption to the conditions of the laboratory host colony.
The final aim of this work was to assist in finding a solution to CpGV resistance for European apple producers. The efficiency of 2016-r4 on RGV did not reach the same level as that on Sv. This difference in efficiency between susceptible and resistant larvae might be considered minor in comparison with the 60,000-fold resistance level observed with CpGV-M. However, field trials with 2016-r4 are required to determine its efficacy as a pest control agent in the field. Three different categories of C. pomonella populations can be found in orchards: populations only composed of susceptible phenotypes, populations mainly composed of resistant phenotypes, and mixed populations. Each type of population may require different pest control strategies. When C. pomonella populations are susceptible to CpGV-M, the use of the 2016-r4 isolate for control is appropriate only when its efficiency is similar to or greater than that of CpGV-M. In contrast, when the C. pomonella population is heterogeneous for the resistance trait, the use of 2016-r4 should be recommended to avoid the proliferation and dispersal of resistant individuals.
This work was supported by the French Research Agency (ANR-06-RIB-003-02) and by NPP. M.B. received a fellowship from the Ecole des Mines d'Alès.
Published ahead of print on 29 December 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»